Log In
Print
BCIQ
Print
Print this Print this
 

VLST-007

  Manage Alerts
Collapse Summary General Information
Company VLST Corp.
DescriptionDimeric protein comprised of human CD47 extracellular domain fused to the Fc portion of a human IgG1 molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat inflammation in autoimmune diseases
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today